Dexcom Inc (DXCM-Q) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$0.47	$0.60	$2.49	$2.98
Number of Estimates	10	9	13	12
High Estimate	$0.53	$0.64	$2.56	$3.29
Low Estimate	$0.42	$0.58	$2.38	$2.73
Prior Year	$0.32	$0.48	$2.09	$2.49
Growth Rate Est. (year over year)	+46.88%	+25.00%	+19.14%	+19.68%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$0.68	$0.61	$0.48	$0.32
Estimate	$0.65	$0.57	$0.45	$0.33
Difference	+0.03	+0.04	+0.03	-0.01
Surprise	+4.62%	+7.02%	+6.67%	-3.03%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.54

3 Mths Ago28

4.54

2 Mths Ago28

4.58

1 Mth Ago26

4.58

Current26

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	28	28	26	26
	22 1	22 1	21 1	21 1
Holds	4	4	3	3
	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says